Drugs / OrthoNovum 1/35
last change Jun 2018 re-read 3 minutes ago

OrthoNovum 1/35

Developed for
ovarian carcinoma

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 0 NCT02155777 Comparator Jun 2014 → Jun 2018 ovarian carcinoma, ovarian cyst University of Michigan Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as OrthoNovum 1/35 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02155777 ↗
Route Oral “Use of oral contraceptives (OCs)” NCT02155777 ↗